XML 74 R54.htm IDEA: XBRL DOCUMENT v3.21.2

Commitments and Contingencies (Details)	Aug. 04, 2021 USD ($) item	Sep. 30, 2021 USD ($)
Loss Contingencies [Line Items]
Number Of Business Days	2
Zealand Pharma
Loss Contingencies [Line Items]
Loss contingency accrual		$ 0
Zealand Pharma | Arbitration Resolution Agreement
Loss Contingencies [Line Items]
Additional milestone payment	$ 1,500,000
Litigation Settlement, Collaborative Arrangement Milestone Payment Reduction Percentage	50.00%
Percentage of reduction in royalty payable	50.00%
Percentage of sales milestone reductions	50.00%
Future development milestone payable	$ 2,750,000
Registration proposal payable	1,000,000.0
Commercial launch expenses	$ 1,750,000
Number of geographic territories | item	3
Zealand Pharma | Arbitration Resolution Agreement | Phase 2 clinical trial
Loss Contingencies [Line Items]
Milestone payment	$ 1,000,000.0
Zealand Pharma | Arbitration Resolution Agreement | Phase 3 clinical trial
Loss Contingencies [Line Items]
Milestone payment	$ 1,500,000

X

- Definition

The amount of future development milestone including commercial launch expenses for launch in the three geographic territories payable under the collaboration agreement.

+ References

No definition available.

+ Details

Name:	ptgx_CollaborativeArrangementCommercialLaunchExpensesPayable
Namespace Prefix:	ptgx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

The amount of future development milestone payable under the collaboration agreement.

+ References

No definition available.

+ Details

Name:	ptgx_CollaborativeArrangementFutureDevelopmentMilestonePayable
Namespace Prefix:	ptgx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

The amount of future development milestone including registration proposal payable under the collaboration agreement.

+ References

No definition available.

+ Details

Name:	ptgx_CollaborativeArrangementRegistrationProposalExpensesPayable
Namespace Prefix:	ptgx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

Represents the percentage of sales milestone reductions resulting from dispute resolution agreement.

+ References

No definition available.

+ Details

Name:	ptgx_LitigationSettlementCollaborativeArrangementMilestonePaymentReductionPercentage
Namespace Prefix:	ptgx_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Represents the percentage of sales milestone reductions resulting from dispute resolution agreement.

+ References

No definition available.

+ Details

Name:	ptgx_LitigationSettlementCollaborativeArrangementSalesMilestonePaymentReductionPercentage
Namespace Prefix:	ptgx_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	instant

X

- Definition

Number Of Business Days.

+ References

No definition available.

+ Details

Name:	ptgx_NumberOfBusinessDays
Namespace Prefix:	ptgx_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Number of geographic territories.

+ References

No definition available.

+ Details

Name:	ptgx_NumberOfGeographicTerritories
Namespace Prefix:	ptgx_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Research And Collaboration Agreement Development Additional Milestone Payable.

+ References

No definition available.

+ Details

Name:	ptgx_ResearchAndCollaborationAgreementDevelopmentAdditionalMilestonePayable
Namespace Prefix:	ptgx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

The amount of development milestone payable under the research and collaboration agreement.

+ References

No definition available.

+ Details

Name:	ptgx_ResearchAndCollaborationAgreementDevelopmentMilestonePayable
Namespace Prefix:	ptgx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

Percentage of reduction in royalty payable.

+ References

No definition available.

+ Details

Name:	ptgx_RoyaltiesOnNetProductSalesPercentagesReduction
Namespace Prefix:	ptgx_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	instant

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_LossContingenciesLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Amount of loss contingency liability.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349

+ Details

Name:	us-gaap_LossContingencyAccrualAtCarryingValue
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Details

Name:	srt_CounterpartyNameAxis=ptgx_ZealandPharmaMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_LitigationCaseAxis=ptgx_ArbitrationResolutionAgreementWithZealandMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_TypeOfArrangementAxis=ptgx_PhaseTwoClinicalTrialMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_TypeOfArrangementAxis=ptgx_PhaseThreeClinicalTrialMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: